Inogen, Inc. (NASDAQ:INGN) marched up 100.04% compared to a 52-week low price of $85.71. The shares were last seen trading -0.71% lower, taking the closing price at $171.45 on 05/24/2018. At recent session, the prices were hovering between $157.43 and $172.8999. This company shares are -14.49% up from its target price of $146.6 and the current market capitalization stands at $3.6B. The recent change has given its price a 16.56% lead over SMA 50 and -9.65% deficit over its 52-week high. The stock witnessed 24.3% gains, 30.73% gains and 38.89% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found INGN’s volatility during a week at 6.25% and during a month it has been found around 4.22%.Inogen, Inc. (INGN) Top Holders
Institutional investors currently hold around $3.69 billion or 99.9% in INGN stock. Look at its top three institutional owners. Novo Holdings A/S owns $612.86 million in Inogen, Inc., which represents roughly 17.02% of the company’s market cap and approximately 16.6% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 2,418,048 shares of the stock are valued at $417.52 million. The third largest holder is Brown Capital Management Llc, which currently holds $390.27 million worth of this stock and that ownership represents nearly 10.84% of its market capitalization.
At the end of 03/31/2018 reporting period, 109 institutional holders increased their position in Inogen, Inc. (NASDAQ:INGN) by some 1,601,705 shares, 109 decreased positions by 1,087,907 and 37 held positions by 18,695,001. That puts total institutional holdings at 21,384,613 shares, according to SEC filings. The stock grabbed 34 new institutional investments totaling 690,046 shares while 23 institutional investors sold out their entire positions totaling 77,747 shares.Inogen, Inc. (NASDAQ:INGN) Insider Trades
Multiple company employees have indulged in significant insider trading. Inogen, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Mcfarland Loren L has sold 2,125 shares of Inogen, Inc. (INGN) in trading session dated May. 11, 2018. These shares are worth $385,560 and were traded at $181.44 each. The SEC filing shows that Wilkinson Scott performed a sale of 9,198 shares. The President and CEO disposed these shares by way of transaction on May. 01, 2018. The company’s shares were given away at $170.35 per share worth to an income of some $1,566,879 on account of Wilkinson Scott.
Director, Anderson Ray Benjamin M, sold 1,000 common shares of Inogen, Inc. (INGN) in the open market. In a transaction dated Apr. 17, 2018, the shares were put up for sale at an average price of $139.82, raking in a sum of $139,820. After this sale, 4,516 common shares of INGN are directly owned by the insider, with total stake valued at $774,268.
In the transaction dated Apr. 16, 2018, the great number of shares disposed came courtesy the EVP, Operations; Scribner Matt disposed a total of 2,500 shares at an average price of $139.79, amounting to approximately $349,475. The insider now directly owns 5,874 shares worth $1,007,097.Inogen, Inc. (INGN) Analyst Guide
Several analysts have released their opinion on Inogen, Inc. (NASDAQ:INGN), with 5 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.